Health News (Reuters)

U.S. Governors urge Trump to make health insurance payments

WASHINGTON (Reuters) - Democratic and Republican U.S. governors on Wednesday urged the Trump administration, as well as Congress, to continue funding payments to health insurance companies that make Obamacare plans affordable, calling it critical to stabilizing the insurance marketplace.

UK finds Roche bladder cancer drug too costly for routine use

LONDON (Reuters) - Britain's healthcare cost-effectiveness agency NICE has decided Roche's new immunotherapy drug Tecentriq is too expensive to justify its routine use to treat bladder cancer, but still hopes it can be used in certain circumstances.

No more freebies: India plans crackdown on marketing by drugmakers

MUMBAI (Reuters) - India, one of the world's largest markets for pharmaceuticals, is drawing up its first set of marketing rules for drugmakers, restricting gifts and trips offered to doctors and pharmacists to 1,000 rupees ($15), according to a draft proposal seen by Reuters.

Veiled marketing: Anti-smoking groups slam Indonesia's Big Tobacco

JAKARTA (Reuters) - Anti-smoking groups in Indonesia have slammed Big Tobacco for promoting sales by giving retailers cash rewards, shopping vouchers and even money to renovate, urging authorities to enforce advertising curbs to safeguard public health.

League considering working with NFLPA on marijuana study

(The Sports Xchange) - The NFL has reached out to the NFL Players' Association in hopes of joining its study of using marijuana as a potential pain management tool for the league's ailing players, according to The Washington Post.

Dog owners more likely to exercise regularly

(Reuters Health) - Dog owners who walk their pets outside are more likely to have regular exercise habits, regardless of weather, according to a new study.

Senate plans September hearings on health insurance market

WASHINGTON (Reuters) - The chairman of the U.S. Senate health committee on Tuesday urged U.S. President Donald Trump to drop his threat to cut government subsidy payments to insurers that make Obamacare plans affordable and allow the payments through September.

Drug enforcement chief criticizes Trump in email to agents

WASHINGTON (Reuters) - The U.S. Drug Enforcement Administration's acting director criticized President Donald Trump for telling law enforcement officers not to be "too nice" to suspects, urging DEA agents to show "respect and compassion" and saying he felt compelled to speak out when "something is wrong."

Daiichi Sankyo settles U.S. lawsuits over blood pressure drug Benicar

NEW YORK (Reuters) - Daiichi Sankyo on Tuesday said it has agreed to pay up to $300 million to settle some 2,300 U.S. cases accusing the Japanese drugmaker of failing to warn that its blood pressure medication Benicar can cause gastrointestinal illness.

Athenahealth to conduct strategic review amid investor pressure

(Reuters) - Athenahealth Inc said it would conduct a strategic review of its operations, more than two months after investor Elliott Management disclosed a stake in the healthcare software provider with the aim of pushing operational and strategic changes at the company.

AstraZeneca gets breakthrough status for blood cancer drug

LONDON (Reuters) - AstraZeneca said on Tuesday that U.S. regulators had awarded its blood cancer drug acalabrutinib "breakthrough" status for the treatment of patients with mantle cell lymphoma, a rare type of blood cancer.

Express Scripts to cover Mylan's EpiPen, exclude rivals

NEW YORK (Reuters) - Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy auto-injectors of other companies.